Glycogen synthase kinase-3β immunoreactivity is reduced in the prefrontal cortex in schizophrenia

Neuroscience Letters

Volumn 302, Issue 2-3, 2001, Pages 117-120

  Beasley, Clare ^a   Cotter, David ^a   Khan, Nadeem ^a   Pollard, Claire ^a   Sheppard, Paul ^b   Varndell, Ian ^b   Lovestone, Simon ^a   Anderton, Brian ^a   Everall, Ian ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Affiniti Research Products Limited   (United Kingdom)

Author keywords

catenin; Dishevelled; Frontal cortex; GSK 3 ; Schizophrenia; Wnt signalling

Indexed keywords

BETA CATENIN; BRAIN PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN DISHEVELLED 2; UNCLASSIFIED DRUG; WNT PROTEIN;

ADULT; AGED; ARTICLE; BRAIN DEVELOPMENT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOARCHITECTURE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOREACTIVITY; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN DETERMINATION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CYTOSKELETAL PROTEINS; FEMALE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PHOSPHOPROTEINS; PREFRONTAL CORTEX; PROTO-ONCOGENE PROTEINS; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 0035917848     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(01)01688-3     Document Type: Article

References (19)

1. Glycogen synthase kinase-3- A new target for lithium's effects in bipolar patients?
2. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development
3. Abnormalities of Wnt signalling in schizophrenia-evidence for neurodevelopmental abnormality
4. Disturbance of Notch-1 and Wnt signalling proteins in neuroglial balloon cells and abnormal large neurons in focal cortical dysplasia in human cortex
5. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia
6. CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia
7. Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation
8. Prenatal developmental disturbances in limbic allocortex of schizophrenics
9. Conservation of dishevelled structure and function between flies and mice: Isolation and characterization of Dvl2
10. Low GSK-3β immunoreactivity in postmortem frontal cortex of schizophrenic patients
11. The phosphorylation of tau: A critical stage in neurodevelopment and neurodegenerative processes
12. The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain
13. Increased expression of Wnt-1 in schizophrenic brains
14. WNTs modulate cell fate and behavior during vertebrate development
15. Gliosis in schizophrenia: A survey
16. The reduced neuropil hypothesis: A circuit based model of schizophrenia
17. Human dishevelled genes constitute a DHR-containing multigene family
18. Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation
19. Dysfunction of protein kinase FA/GSK-3 alpha in lymphocytes of patients with schizophrenic disorder